Best Chest X-Ray Doctors Abroad

Zhang Jinshan, male, China’s First M.D. in the Radiation Medicine, CCI (Chinese College of Interventionalists) Master Interventionalist, Director of the Department of Former Radiological Diagnosis at Chinese PLA General Hospital(No.3 in China) Ph.D. of Medicine, Nagasaki University, Japan.

1980–1985: Completed doctoral studies at Nagasaki University, Japan

1968–present: Department of Radiology, Chinese PLA General Hospital

1988: Third Prize of the Military Science and Technology Progress Award

1989–present: Member of Radiological Society of North America(RSNA)

1990–2009: Standing Committee Member of the Radiology and Therapeutic Radiology Committee of the PLA

1991: Second Prize of the Military Science and Technology Progress Award

1992–2008: Group Leader of the Group of Intervention of Chinese Journal of Radiology

1992–2015: Standing Editorial Board Member and Editorial Board Member of Journal of Interventional Radiology

1993: Granted the Lifetime Special Government Allowance of the State Council

1993–2012: Deputy Chief Editor of Chinese Journal of Medical Image Technology

1994: Third Prize of the Military Science and Technology Progress Award

1997: Second Prize of the Military Science and Technology Progress Award

1997–2009: Standing Member of Chinese Society of Radiology

1999: Third Prize of the Military Science and Technology Progress Award

1999–2010: Deputy Director Member of Chinese Society of Interventional Oncology

2002: Second Prize of the Military Science and Technology Progress Award

2005: Third Prize of the Military Science and Technology Progress Award

Member of Radiological Society of North America(RSNA)

Standing Member of Chinese Society of Radiology

Group Leader of the Group of Intervention of Chinese Journal of Radiology

Deputy Director Member of Chinese Society of Interventional Oncology

Director Member of Beijing Medical Association Society of Interventional Radiology

Deputy Chief Editor of Chinese Journal of Medical Image Technology

Standing Member of Professional Committee of Radiological Medicine of the Chinese People’s Liberation Army

Standing Editorial Board Member and Editorial Board Member of Journal of Interventional Radiology

Awarded the Special Government Allowance of the State Council

Awarded three Second Prizes and four Third Prizes for Military Science and Technology Progress.

Awarded the honorary title of “Chinese College of Interventionalists(CCI) Master Interventionalist”

Led multiple national and provincial/ministerial scientific research projects, including two projects funded by the National Natural Science Foundation of China and two projects funded by the Department of Science and Technology of Sichuan Province.

In the pioneering development of interventional medicine in China, Zhang Jinshan has been an indispensable founder and leading figure. As China’s first overseas-trained doctoral graduate in radiological medicine, he returned to China in the 1980s after completing his studies abroad and introduced cutting-edge international interventional technologies to the country. Over more than four decades of dedicated practice and research, he has helped propel Chinese interventional medicine from its infancy to a position at the forefront of the global field through his exceptional clinical expertise and profound academic accomplishments.

Professor Zhang Jinshan has long been dedicated to the field of medical imaging and has developed distinctive expertise in selective and superselective interventional diagnosis and treatment for solid tumors such as liver cancer, demonstrating exceptional technical proficiency and profound academic accomplishment. Beginning in the 1990s, he led his team in pioneering the clinical application and research of TIPSS and B-ORTO in China, filling major gaps in the domestic field and opening new paths for the interventional management of gastrointestinal bleeding caused by portal hypertension secondary to liver cirrhosis. In addition, he has made groundbreaking contributions to the interventional diagnosis and treatment of peripheral vascular diseases, as well as to preoperative embolization for spinal tumors.

In the field of liver cancer treatment, Professor Zhang Jinshan not only led the development of standardized treatment protocols for liver cancer but also pioneered Transcatheter Arterial Chemoembolization with temporary Hepatic Vein Thrombosis (TACE-THVO) for primary liver cancer, bringing the efficacy of interventional therapy to a new level. In recognition of his outstanding clinical and scientific contributions, he was awarded the honorary title of “Chinese Master of Interventional Radiology” at the 2019 annual conference of the Chinese College of Interventionalists.

Professor Zhang Jinshan is not only a master clinician but also a driving force in the development of the discipline and a dedicated mentor in talent cultivation. He led his team in establishing one of China’s premier interventional therapy centers. As a doctoral supervisor, he has trained a large number of outstanding specialists and future leaders in interventional medicine, with many of his students and protégés now serving across the country. Academically, he has led multiple key national and military research projects, published more than 300 academic papers, and served as chief editor of three monographs, making remarkable contributions to the establishment of China’s academic framework for interventional medicine and the nationwide dissemination of its technologies.

From the laboratory to the operating room, and from academic podiums to grassroots hospitals, Professor Zhang Jinshan has consistently upheld the principles of “pioneering, innovation, pragmatism, and compassion". He has devoted his life to fulfilling the mission of a physician—relieving patients’ suffering through minimally invasive techniques and advancing the discipline through academic excellence—thereby establishing himself as a truly towering figure and one of the foremost authorities in the field of interventional medicine in China.

Professor Zhang Jinshan’s Academic Achievements

Professor Zhang Jinshan has achieved prolific academic accomplishments, having published over 300 academic papers covering areas such as interventional therapy for liver cancer, minimally invasive treatment of portal hypertension, interventional treatment of vascular diseases, and tumor ablation.

Selected Publications by Professor Zhang Jinshan

1. Zhang Jinshan, Wang Maoqiang. Experiments and Clinical Studies of transjugular intrahepatic portosystemic stent shunt (TIPSS). Chinese Journal of Radiology, 1993，27（6）：361-365.

Professor Zhang Jinshan is the first author. This is one of the early research papers in China that systematically elaborates on the TIPSS technique. Through animal experiments and clinical case analysis, it confirmed that TIPSS is a safe and effective minimally invasive method for treating portal hypertension and its complications, laying an important foundation for the promotion and application of this technique in China.

2.Zhang Jinshan, Li Huai. Clinical study on transcatheter arterial embolization with temporary hepatic vein occlusion for the treatment of primary liver cancer.Chinese Journal of Radiology, 1996，30（8）：521-524.

Professor Zhang Jinshan is the first author. He innovatively proposed the technique of "transcatheter arterial embolization with temporary hepatic vein occlusion." Clinical results demonstrated that this method can significantly increase the drug concentration within liver cancer lesions, reduce damage to normal liver tissue, and effectively improve the therapeutic outcomes for intermediate and advanced liver cancer, providing a novel strategy for the interventional treatment of liver cancer.

3. Zhang Jinshan, Wang Maoqiang, Li Huai. Interventional treatment of Budd-Chiari syndrome. Chinese Journal of Medical Imaging Technology, 1998，14（3）：189-191.

Professor Zhang Jinshan is the first author. This paper systematically summarizes the early experience in interventional treatment of Budd-Chiari syndrome in China, elaborating in detail on the key operational points and therapeutic efficacy of techniques such as percutaneous transluminal angioplasty and stent placement. It confirms that interventional therapy is the preferred minimally invasive method for Budd-Chiari syndrome, promoting the standardized development of treatment for this disease.

4.Zhang Jinshan, Li Huai, Wang Maoqiang. Clinical value of superselective hepatic arterial chemoembolization in the treatment of hypovascular liver cancer. Chinese Journal of Radiology, 2000，34（5）：335-337.

Professor Zhang Jinshan is the first author. Addressing the challenges in interventional treatment of hypovascular liver cancer, this paper explores the clinical efficacy of superselective hepatic arterial chemoembolization. The results indicate that this technique can precisely target the lesions and improve the treatment response rate, providing an important clinical basis for the interventional treatment of hypovascular liver cancer.

5. Zhang Jinshan, Li Huai, Wang Maoqiang. Interventional treatment of peripheral vascular stenosis and occlusion.Chinese Journal of Radiology, 2002，36（7）：612-614.

Professor Zhang Jinshan is the first author. This paper summarizes the interventional treatment experience of over 400 patients with peripheral vascular stenosis and occlusion, analyzing the indications and efficacy of techniques such as balloon angioplasty and stent placement. It confirms that interventional therapy is a safe and effective approach for peripheral vascular diseases, providing practical support for its clinical promotion.

6.Zhang Jinshan, Li Huai, Wang Maoqiang. Clinical application of CT-guided percutaneous puncture ablation in the treatment of abdominal tumors. Chinese Journal of Medical Imaging Technology, 2004，20（9）：1395-1397.

Professor Zhang Jinshan is the first author. This paper explores the application value of CT-guided percutaneous puncture techniques such as radiofrequency ablation and chemical ablation in the treatment of abdominal tumors. The clinical results show that this method is minimally invasive with reliable efficacy, offering a minimally invasive treatment option for patients with inoperable abdominal tumors.

7.Zhang Jinshan, Wang Maoqiang, Li Huai. Advances in the application of interventional therapy for benign prostatic hyperplasia. Chinese Journal of Radiology, 2006，40（8）：876-878.

Professor Zhang Jinshan is the corresponding author. This paper systematically reviews the cutting-edge advances in interventional therapy for benign prostatic hyperplasia, including the principles, procedures, and efficacy of techniques such as prostatic artery embolization and stent placement, providing new insights for the minimally invasive treatment of benign prostatic hyperplasia.

8.Zhang Jinshan, Li Huai, Wang Maoqiang. Discussion on the standardization of interventional therapy for liver cancer. Chinese Journal of Practical Surgery, 2008，28（10）：856-858.

Professor Zhang Jinshan is the corresponding author. Drawing on years of clinical experience and research findings, he led the discussion on standardized protocols for interventional therapy of liver cancer, covering key aspects such as preoperative assessment, treatment modality selection, and postoperative management, providing important references for the formulation of clinical guidelines for interventional therapy of liver cancer in China.

Professor Zhang Jinshan co-authored monographs

1. Interventional Radiology (People's Military Medical Press, 1995): The first monograph in China to systematically discuss the theories and techniques of interventional radiology. It comprehensively elaborates on the interventional diagnosis and treatment system for tumors, vascular diseases, and non-vascular diseases, becoming a classic essential textbook for interventional physicians in China.

2.Interventional Therapy for Liver Cancer (People's Health Press, 2001): Focusing on minimally invasive interventions for liver cancer, this book systematically summarizes techniques such as TACE, ablation, and vascular intervention, refines operational standards and the prevention and management of complications, and promotes the standardization of interventional therapy for liver cancer.

3.Interventional Treatment of Portal Hypertension (Science Press, 2005): This book systematically elaborates on minimally invasive techniques for portal hypertension, such as TIPSS and B-ORTO, covering experimental research, clinical procedures, long-term follow-up, and efficacy evaluation, filling the gap in monographs on interventional treatment of portal hypertension in China.

Professor Zhang Jinshan’s Research project

1.The National "Eighth Five-Year Plan" Scientific and Technological Key Project—Clinical and Basic Research on Comprehensive Interventional Therapy for Liver Cancer (Project Leader): This project systematically explored multimodal interventional strategies for liver cancer, established the core regimen of superselective TACE combined with local ablation, and significantly improved the therapeutic outcomes for intermediate and advanced liver cancer.

2.The Military "Ninth Five-Year Plan" Key Medical Scientific Research Project—Standardized Research on TIPSS for the Treatment of Portal Hypertension (Project Leader): This project formulated China's first operational standards and postoperative management guidelines for TIPSS, reduced the incidence of complications, and promoted the popularization of this technique throughout the military and across the country.

3.National Natural Science Foundation of China Project — Research on the Mechanism of Targeted Therapy for Liver Cancer Using Hepatic Vein Occlusion Combined with Chemoembolization (Project Leader): This project revealed the synergistic enhancement mechanisms of the innovative technique at the levels of hemodynamics, drug metabolism, and the tumor microenvironment, providing theoretical support for precision interventional therapy of liver cancer.

4.Military Clinical High-Tech Major Project-Establishment and Clinical Application of the Interventional Treatment Technology System for Complex Vascular Diseases (Project Leader): This project overcame interventional challenges in complex lesions such as Budd-Chiari syndrome, peripheral vascular occlusion, and vascular malformations, forming a complete technical system that has been promoted and applied widely.

Professor Ilhan Mavioglu is a highly specialized cardiovascular surgeon at Optimed International Hospital. Chest x-ray screening is a vital tool he uses to evaluate patients for minimally invasive heart and vascular procedures.

• Holds the title of Professor and serves at the Cardiovascular Surgery Outpatient Clinic
• Trained at Great Ormond Street Hospital in London, a premier international medical center
• Specializes in minimally invasive anaortic coronary artery bypass and complex vascular surgery
• Published numerous articles in SCI journals on heart valve repair and aortic treatments
• Member of the European Association of Cardiovascular Surgery and other international bodies

Dr. Jang Hyo Kim is an orthopedic surgeon at Leadheal Hospital in Seoul. He specializes in joint preservation and complex reconstruction. He completed a fellowship in Ilizarov external fixation surgery in Russia. Dr. Kim currently serves as the Joint Center Director at Very Good Hospital. He is an adjunct professor at Kyung Hee University.

• Performs arthroscopy and replacement for the shoulder, knee, and hip.
• Treats spinal conditions using instrumentation, fusion, and discectomy.
• Holds TPI therapy certification for muscle and joint pain management.
• Full member of the Korean Orthopaedic Association and the Korean Hip Society.

Professor Marek Zbigniew Synder is a senior specialist in orthopedic surgery and musculoskeletal traumatology. He has decades of clinical, research, and academic experience. He earned his PhD in 1982. He completed his DSc (habilitation) in 1993. He became Professor of Medicine in 1998. He served as Regional Consultant in Orthopedics and Traumatology for the Łódź Voivodeship.

Clinical focus: pediatric orthopedics, limb lengthening, joint replacement (arthroplasty), and tendon surgery. He also performs in‑office, high‑resolution musculoskeletal ultrasound (USG) for precise diagnosis.

Academic output and mentoring: trained over 20 specialists. Co‑author of textbooks for orthopedic surgeons. Author or co‑author of about 400 scientific papers in Polish and international journals.

Dr. Hwang Dongin is a pulmonologist in pulmonary and critical care. He specializes in pneumonia, pulmonary tuberculosis, chronic cough, chronic lung diseases, allergic rhinitis, asthma, and pulmonary intensive care.

At Daelim Saint Mary's Hospital, he serves as Chief/Senior Chief of Pulmonology and as a Designated Attending Physician. He is also Director of Medical Training and the Medical Cooperation Center, and serves as CMO. He is a Clinical Professor at the Catholic University of Korea St. Mary's Hospital. He is an affiliated physician with Samsung, Asan, Severance, and Chung-Ang University Hospitals. He serves on the KMA Advisory Committee. He is a lifetime member of the Korean Academy of Tuberculosis and Respiratory Diseases. He is a full member of KASLC and KAAACI. He is an appointed Special Manuscript Reviewer for the Korean Society of Cardiology. He is a member of the Asthma and COPD research groups.

Dr. Kurt Rasche is the Chief of Pulmonology at Helios University Hospital Wuppertal. He heads the certified Lung Cancer Center and the department of sleep medicine. With decades of clinical practice, he focuses on chronic lung diseases and breathing disorders. Dr. Rasche treats patients at a hospital seeing 150,000 people annually.

• Specialist in internal medicine, pulmonology, allergology, and intensive care.
• Treats complex conditions including COPD, asthma, pneumonia, and lung cancer.
• Performs bronchoscopic balloon dilatation and lung cancer surgery.
• Leads a center certified by the German Cancer Society.

Dr. Lee Nagwon is a pulmonologist and critical care specialist. He is the Chief Medical Officer of Pulmonology at Naeun Hospital. His expertise includes pneumonia, pulmonary tuberculosis, chronic cough, chronic lung diseases, allergic rhinitis, asthma, and pulmonary intensive care.

He earned an MD and an MS in Medicine from Yonsei University. He completed his internship, internal medicine residency, and a pulmonology fellowship at Yonsei University Wonju Severance Christian Hospital. He has served as an adjunct professor at Yonsei University Wonju College of Medicine. He has also served as a clinical professor at Gachon University College of Medicine and Inha University College of Medicine. He is a full member of The Korean Association of Internal Medicine and The Korean Academy of Tuberculosis and Respiratory Diseases. He authored “The Effects of Bronchoscope Diameter on the Diagnostic Yield of Transbronchial Lung Biopsy of Pulmonary Nodules.”

Dr. Woo Kyung Kwak is an orthopedic surgeon at Leadheal Hospital in Seoul. He specializes in minimally invasive bunion correction using the MICA technique. Dr. Kwak also performs total knee arthroplasty and arthroscopic joint surgery. He completed the FIFA Diploma in Football Medicine for sports injury management.

• Completed training at the Arthrex Surgical Skills Laboratory and the AO Trauma course.
• Served as the Chief of Orthopedic Surgery at Armed Forces Daejeon Hospital.
• Maintains membership in the Korean societies for orthopedics, arthroscopy, and sports medicine.
• Acts as a scientific reviewer for international Springer Nature medical journals.

Op. Dr. Tansu Gürsoy is a brain and nerve surgery specialist at Çerkezköy Private Optimed Hospital. He completed his training at Ankara Training and Research Hospital. His practice focuses on spine surgery. Key areas include degenerative scoliosis, herniated discs, spinal stenosis, trauma, and tumors.

In 2019, he won third place from the Turkish Neurosurgery Association for a paper on prebending rods and sagittal parameters in lumbar degenerative scoliosis. He co-authored Chapter 75 (Lenke-Silva Classification & Adult Degenerative Scoliosis) in The Aging Spine. His thesis analyzed screw malposition in 415 thoracolumbar pedicle fixation cases.

He is a member of the Turkish Neurosurgery Association (Spinal & Peripheral Nerve Surgery Group), the Turkish Spine Association, and the Turkish Medical Association. He completed the Advanced Spinal Surgery Course and the Hands-on Microvascular Anastomosis & Microsurgery training. He holds a Category A Certificate for Experimental Animals. He also attends major spine congresses.

Professor Kim Ki-bong specializes in CABG, valve surgery, atrial fibrillation, and heart transplantation. He is Director of the Cardiac Surgery and Cardiovascular Centers at Myongji Hospital. He pioneered advanced coronary bypass in Korea. He has extensive OPCAB experience and works on the TECAB team using the da Vinci Xi.

In 2025, his team performed Korea’s first totally endoscopic CABG without cardiopulmonary bypass. In August 2026, they achieved the nation’s first multivessel TECAB.

He is former Chair of Thoracic and Cardiovascular Surgery at Seoul National University College of Medicine. He is also former Chief of the same department at Seoul National University Hospital. He serves on the Editorial Board of The Annals of Thoracic Surgery. He is a member of AATS, STS, and EACTS. He is a past President of the Korean Societies of Coronary Artery Surgery, Surgical Treatment of Arrhythmias, and Thoracic and Cardiovascular Surgery. His research includes 130+ international and 140+ Korean papers. He has given 80+ international and 80+ Korean lectures. He earned his MD, Master’s, and PhD at Seoul National University.

Dr. Yaacov Lawrence is the Chair of Radiation Oncology at Sheba Medical Center. He specializes in precision radiation therapy and neuro-oncology. Dr. Lawrence pioneered celiac plexus radiosurgery for pancreatic cancer pain management. He holds the FASTRO designation, one of the highest honors in his specialty.

• Leads the Gastrointestinal Cancer Program at Sheba Medical Center.
• Performs stereotactic radiosurgery for brain tumors and nervous system cancers.
• Authored over 280 scientific publications on personalized radiation protocols.
• Completed radiation oncology fellowship training at Thomas Jefferson University.

Dr. Elad Jacoby is a pioneer of pediatric CAR T–cell therapy in Israel. He heads the Pediatric Cell Therapy Center at Sheba Medical Center. Dr. Jacoby specializes in treating relapsed and high-risk pediatric leukemias and lymphomas. He completed fellowships at Johns Hopkins and the U.S. National Cancer Institute.

• Medical Director of the Advanced Biotherapy Center at Sheba Medical Center.
• Authored over 240 scientific publications in pediatric hemato-oncology.
• Board-certified in both Pediatrics and Pediatric Hematology and Oncology.
• Leads the integration of CAR T–cell therapy with bone marrow transplantation.

Dr. Ercan Kocakoc is a prize-winning radiologist at Medical Park Bahcelievler Hospital in Istanbul. He won 1st Prize at the 2009 ESGAR congress for clinical cases. Dr. Kocakoc specializes in interventional radiology and advanced body imaging. He completed a research fellowship at the University Hospital of Cleveland in the USA.

• Performs liver chemoembolization and radioembolization for cancer patients.
• Treats urological conditions through procedures like varicocele embolization.
• Held former chairmanship roles at Bezmialem Vakif and Yeditepe Universities.
• Fellow of the European Society of Gastrointestinal and Abdominal Radiology.

The doctor is a highly trained cardiologist with extensive clinical expertise in the diagnosis and management of complex cardiovascular conditions. The doctor's professional focus includes the treatment of hypertension, cardiovascular occlusion, heart failure, and heart rhythm disorders. Additionally, the doctor is skilled in addressing high cholesterol and managing congenital heart disease.

The doctor completed medical training at Azerbaijan Medical University and subsequently underwent specialized cardiology training at Kocaeli University Faculty of Medicine, spanning from 2017 to 2023. Through this rigorous academic and clinical background, the doctor provides comprehensive care for patients with diverse cardiac health needs.

Dr. Hasan Kalkan is an orthopedic surgeon at Büyük Anadolu Hospitals in Istanbul. He specializes in arthroscopic surgery and total joint replacements for the knee, hip, and shoulder. Dr. Kalkan graduated from the prestigious Cerrahpaşa Faculty of Medicine. He treats complex musculoskeletal issues, including ligament tears and bone fractures.

• Performs anterior cruciate ligament reconstruction and arthroscopic meniscectomy.
• Surgical expert in correcting valgus deformity and hallux valgus (toe deformity).
• Performs soft tissue tumor mass excision and trauma surgery.
• Works at a facility that uses robotic-assisted techniques for faster recovery.

The doctor specializes in the comprehensive diagnosis and treatment of respiratory conditions, including asthma, allergic diseases, and chronic obstructive pulmonary disease (COPD). Expertise encompasses the management of lung infections, tuberculosis, and the clinical evaluation of lung cancer.

In addition to pulmonary care, the doctor is proficient in performing bronchoscopy procedures and conducting polysomnography for the assessment and diagnosis of sleep apnea.

The doctor specializes in the comprehensive management of cardiovascular conditions, with a clinical focus on coronary artery diseases, including cardiovascular occlusion and myocardial infarction. Expertise extends to the treatment of hypertension, hyperlipidemia, and heart failure.

Furthermore, the doctor provides specialized care for heart valve diseases, rhythm disorders (arrhythmias), and peripheral vascular conditions, specifically addressing leg and cervical vascular diseases.

The doctor is a highly skilled specialist in orthopedics and traumatology, with extensive clinical expertise in the diagnosis and treatment of complex spinal conditions, including scoliosis, spinal canal stenosis, and various spinal fractures or slippage issues. The doctor provides comprehensive care for degenerative and traumatic conditions affecting the musculoskeletal system.

In addition to spinal care, the doctor specializes in advanced joint reconstruction and orthopedic surgery, focusing on knee and hip prosthesis procedures. The clinical practice also encompasses the management of shoulder and knee pathologies, as well as specialized treatments for foot and ankle disorders, heel spurs, and chronic coccyx pain.

The doctor is a highly specialized orthopedic surgeon with a primary focus on pediatric orthopedics. Clinical expertise includes the management and treatment of hip dislocations, as well as complex hip and knee arthroplasty procedures.

In addition to joint reconstruction, the doctor possesses extensive experience in the surgical treatment of fractures and dislocations. Furthermore, the doctor provides comprehensive care for patients suffering from various sports-related injuries, utilizing advanced surgical techniques to restore mobility and function.